INDV·45579U109·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-Activist
INDV (INDIVIOR PHARMACEUTICALS INC) is held by 137 institutional investors as of Q1 2026. Largest holders: MILLENNIUM MANAGEMENT LLC ($140.1M), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ($70.8M), UBS Group AG ($66.8M). Net institutional sentiment: Bullish.
See how INDV's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer